What is Jude Bio?
Jude Bio is at the forefront of pioneering oligonucleotide medicines specifically designed for delivery to the kidney. This innovative approach opens new avenues for RNA-based therapies targeting both systemic and renal diseases. The company's proprietary STRIKE (Selectively Targeting RNA Into KidnEy) platform utilizes a unique, endogenous mechanism to precisely direct oligonucleotide medicines to the kidney. Jude Bio's current drug development pipeline focuses on ligand-siRNA conjugate drugs engineered for receptor-mediated uptake by specific kidney cell types, aiming to achieve gene silencing for disease-modifying target genes in systemic conditions.
How much funding has Jude Bio raised?
Jude Bio has raised a total of $100M across 1 funding round:
Angel/Seed
$100M
Angel/Seed (2024): $100M with participation from Atlas Venture, The Column Group, and TCG
Key Investors in Jude Bio
Atlas Venture
Atlas Venture is a venture capital firm specializing in early-stage biotechnology, focusing on creating and building companies that translate scientific advancements into life-changing medicines.
The Column Group
The Column Group (TCG) is a venture ecosystem dedicated to advancing life sciences innovation, supporting the formation and growth of biotechnology companies through its edge-to-edge investment model.
TCG
TCG Inc provides information technology and management advisory services to federal government agencies, with core competencies in Agile development, shared services optimization, budget support, and health science analytics.
What's next for Jude Bio?
With the recent major strategic investment, Jude Bio is poised for accelerated growth and the advancement of its therapeutic pipeline. The substantial capital will likely fuel further research and development, clinical trial progression, and the scaling of its innovative STRIKE platform. This funding round signals strong investor confidence in Jude Bio's potential to address unmet needs in kidney diseases and systemic conditions through targeted RNA medicine, positioning the company for significant milestones in the near future.
See full Jude Bio company page
